The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and Beyond

By afschroeder • May 1, 2026

Chauhan A, Hendifar AE, El-Haddad G, Soares HP, Herrmann K. The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and Beyond. J Nucl Med. 2026 Apr 30:jnumed.126.272026. doi: 10.2967/jnumed.126.272026. Epub ahead of print. PMID: 42061947.

Tags: 505(b)(2), Cedars Sinai DoM, Hematology/Oncology, lexicon, oncology, Publications, radiopharmaceutical therapy, regulatory

Gene-by-Sleep Duration Interaction for Glycemic Traits in More Than 480,000 Individuals

Wang H, Nagarajan P, Miller CL, Bentley AR, Noordam R, Westerman KE, Brown MR, Kraja AT, O'Connell JR, Schwander K, Li C, Sanghvi MM, Song[...]

Prediction of All-Cause Mortality, Cardiovascular Mortality, and Angiographic Coronary Disease From LVEF Reserve: Findings From the Multicenter REFINE PET Registry

Hijazi W, Zhou J, Miller RJH, Ramirez G, Lemley M, Shanbhag A, Kwiecinski J, Kavanagh PB, Parekh T, Liang JX, Alexanderson E, Carvajal-Juarez I, Slipczuk[...]

Conversational artificial intelligence for geriatric screening: A mixed-methods feasibility study

Naeim A, Cheng J, Spiegel B, Bakshian A, Tetrault E, Mehra M, Amini D, Krut Z, Shang H, Sedrak MS, Bui A, Johnson T, Wang[...]